• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AD

FDA approves anti-amyloid therapy for Alzheimer’s disease

August 17, 2023  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Targeting amyloid in AD – optimism amid controversy

January 15, 2020  

Pre-AAN Survey

March 27, 2019  

Two trials terminated in Alzheimer’s disease

January 31, 2019  

Third failed trial for solanezumab in AD

February 22, 2018  

IVIG: limited benefit in Alzheimer’s disease

August 2, 2017  

AAN 2017 DAILY REPORT

April 27, 2017  

Sun avoidance – more harm than good?

December 16, 2016  

Gum disease linked to cognitive decline in AD

December 7, 2016  
1
2
3
Next

Browse by Topic

MS (370)
AD (83)
PD (78)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
BIOMARKERS IN MS (33)
MIGRAINE (26)
SCHIZOPHRENIA (25)
EPILEPSY (22)
STROKE (22)
Library (14)
ECTRIMS 2015 (13)
CLINICAL CASES IN MS (12)
AAN 2015 (11)
ECTRIMS 2019 (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2021 (10)
AAN 2014 (9)
ECTRIMS 2013 (9)
MS SEQUENCING (9)
ECTRIMS 2018 (9)
AAN 2013 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2019 (7)
ECTRIMS 2017 (6)
ECTRIMS 2022 (6)
AAN 2021 (6)
CHARCOT 2013 (6)
ECTRIMS 2016 (5)
ECTRIMS-ACTRIMS 2023 (5)
ANXIETY (5)
AAN 2022 (5)
CCSVI (5)
BIPOLAR (5)
BPD (4)
AAN 2023 (4)
NeuroSound (4)
EAN 2015 (4)
EAN 2022 (3)
ENS 2013 (3)
AAN 2017 (3)
EAN 2023 (3)
PAIN (3)
AAN 2020 (3)
SLEEP (2)
EAN 2020 (2)
CMSC 2023 (2)
NEW DRUGS (2)
SPECIAL REPORT (2)
AAN 2018 (2)
APA 2014 (2)
GUIDELINES (1)
ACTRIMS 2022 (1)
CONCUSSION (1)
ACTRIMS 2023 (1)
LUMBAR PUNCTURE (1)
NEWS IN BRIEF (1)
ECTRIMS (1)
EAN (1)
EAN 2021 (1)
WEST NILE (1)
APA 2016 (1)
ALS (1)
SEIZURE (1)
LGS (1)
hATTR (1)
Dravet syndrome (1)
CIDP (1)
ADDICTION (1)
EAN 2019 (1)
TSC (1)
INSOMNIA (1)
AAN 2016 (1)
BIOMARKERS (0)
EAN 2016 (0)
ECTRIMS 2020 (0)
AAN (0)
View all Topics

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • CNS effects of Wegovy (semaglutide) posted on February 28, 2023
  • Biomarkers after stopping treatment may identify at-risk MS patients posted on November 30, 2023
Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions